Correlations between carotid IMT, factor VIII activity level and metabolic disturbances: A cardio-vascular risk factor in the HIV positive persons

被引:6
作者
de Saint Martin, Luc [1 ]
Pasquier, Elisabeth [1 ]
Vandhuick, Olivier [1 ]
Arnaud, Bertrand [1 ]
Vallet, Sophie [1 ]
Duchemin, Jerome [1 ]
Bellein, Veronique [1 ]
Bressollette, Luc [1 ]
机构
[1] Brest Univ Hosp, Brest, France
关键词
D O I
10.2174/157016207780636498
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the HIV infection, the short time-scale between the HIV-induced cardiovascular events and the onset of antiretroviral therapy elicits a thrombophilic co-factor that worsens the induced atherosclerosis. We compared the factor VIII plasma activity, previously implicated in arterial and venous thrombosis, with a Surrogate marker of atherosclerosis, the carotid intima-media thickness, and with the usual atherosclerosis risk factors in 154 HIV infected outpatients. The FVIII plasma activity is significantly associated with the carotid intima-media thickness and, strongly, with blood glucose and triglycerides levels. A raised FVIII plasma activity is an important feature of the metabolic syndrome and a putative co-factor of HAART induced cardiovascular events. Thus the prevention of the HAART-induced cardio-vascular events should probably not be exclusively focused oil atherosclerosis but likewise on the thrombus formation process.
引用
收藏
页码:361 / 364
页数:4
相关论文
共 22 条
[1]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[2]  
CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380
[3]   Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status [J].
Devaraj, S ;
Rosenson, RS ;
Jialal, I .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2004, 33 (02) :431-+
[4]   Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults - The ARIC study [J].
Duncan, BB ;
Schmidt, MI ;
Chambless, LE ;
Folsom, AR ;
Carpenter, M ;
Heiss, G .
OBESITY RESEARCH, 2000, 8 (04) :279-286
[5]   ASSOCIATION OF HEMOSTATIC VARIABLES WITH PREVALENT CARDIOVASCULAR-DISEASE AND ASYMPTOMATIC CAROTID-ARTERY ATHEROSCLEROSIS [J].
FOLSOM, AR ;
WU, KK ;
SHAHAR, E ;
DAVIS, CE .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12) :1829-1836
[6]   Cardiovascular disease risk factors in HIV patients -: association with antiretroviral therapy.: Results from the DAD study [J].
Friis-Moller, N ;
Weber, R ;
Reiss, P ;
Thiébaut, R ;
Kirk, O ;
Monforte, AD ;
Pradier, C ;
Morfeldt, L ;
Mateu, S ;
Law, M ;
El-Sadr, W ;
De Wit, S ;
Sabin, CA ;
Phillips, AN ;
Lundgren, JD .
AIDS, 2003, 17 (08) :1179-1193
[7]   Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans [J].
Fultz, SL ;
McGinnis, KA ;
Skanderson, M ;
Ragni, MV ;
Justice, AC .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (06) :420-423
[8]   Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines [J].
He, G ;
Andersen, O ;
Haugaard, SB ;
Lihn, AS ;
Pedersen, SB ;
Madsbad, S ;
Richelsen, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (09) :583-590
[9]   Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: A case series [J].
Jacobson, MC ;
Dezube, BJ ;
Aboulafia, DM .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (08) :1214-1222
[10]   Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk [J].
Juhan-Vague, I ;
Alessi, MC ;
Mavri, A ;
Morange, PE .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1575-1579